Table 2

Participants’ comorbidities and smoking status

COVID-19 hospitalised (n=24)COVID-19 self-isolated (n=31)Controls (n=44)P value
(significant
for <0.05)
Chronic rhinosinusitis1 (6.7%)01 (2.3%)0.427
Allergies03 (10.0%)11 (25.6%) 0.042
Lung disease2 (6.7%)2 (13.3%)3 (7.0%)0.755
Hypertension6 (40.0%)5 (16.7%)10 (23.3%)0.252
Diabetes1 (6.7%)04 (9.3%)0.193
Obesity4 (26.7%)03 (7.0%) 0.011
Head injury003 (7.0%)0.283
Heart disease2 (13.3%)02 (4.7%)0.113
Cancer, no CTX/RTX01 (3.3%)1 (2.3%)1.000
Cancer, treated with CTX/RTX1 (6.7%)000.170
Smoking1 (6.7%)3 (10.7%)4 (11.4%)1.000
  • Results are presented as number of cases and percentage . Values of p were obtained by Fisher’s exact test.

  • CTX, chemotherapy; RTX, radiotherapy.